Literature DB >> 6498570

Isolated regional perfusion; anaesthetic technique, monitoring and blood replacement.

M E Goldberg, H M Rosenblum, J L Seltzer, F E Rosato.   

Abstract

Isolated regional perfusion for the treatment of malignant melanoma is an accepted method of treatment. No standard of anaesthetic practice has been established for those individuals. Perioperative records of patients undergoing isolated limb perfusion were studied to determine adequate blood replacement. Records were examined and compared for (1) age, (2) ASA physical status, (3) presence of associated disease, (4) anaesthetic technique, (5) the amount of blood and fluid replacement, (6) preoperative haemoglobin (hgb) and haematocrit (hct) and postoperative serial complete blood counts. Fifteen patients were studied (mean age 53 +/- 16 yrs). Mean blood and fluid replacement was: packed red blood cells; 2.28 +/- 0.82 units, 722 +/- 17 ml of 5 per cent albumin, 1747 +/- 21 ml crystalloid. There were twelve Physical Status Class I or II and three Class III patients. All patients received general anaesthesia. There was a statistically significant difference in the preoperative and postoperative values for haemoglobin and haematocrit (p less than 0.01) with no difference between the postoperative and discharge values. Adequate blood replacement was determined by the equation: (Formula: see text) Extensive invasive monitoring is not routinely required for adequate blood replacement or the detection of leaks between the systemic and isolated circulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498570     DOI: 10.1007/bf03009542

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  19 in total

1.  Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.

Authors:  C M McBride; E V Sugarbaker; R C Hickey
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

2.  Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit.

Authors:  O CREECH; E T KREMENTZ; R F RYAN; J N WINBLAD
Journal:  Ann Surg       Date:  1958-10       Impact factor: 12.969

3.  Cardiovascular responses to sustained high skin temperature in resting man.

Authors:  L B Rowell; G L Brengelmann; J A Murray
Journal:  J Appl Physiol       Date:  1969-11       Impact factor: 3.531

4.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

5.  Perfusion chemotherapy for recurrent melanoma of extremity: a progress report.

Authors:  W W Shingleton
Journal:  Ann Surg       Date:  1969-06       Impact factor: 12.969

6.  The use of regional chemotherapy in the management of malignant melanoma.

Authors:  E T Krementz; R D Carter; C M Sutherland; M Campbell
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

7.  Cytotoxics and hyperthermic perfusion: a preliminary study.

Authors:  J Tonak; P Hermanek; H Banz; H Groitl
Journal:  Cancer Treat Rev       Date:  1979-06       Impact factor: 12.111

8.  A retrospective study of regional perfusion for melanoma.

Authors:  D E Wagner
Journal:  Arch Surg       Date:  1976-04

9.  Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.

Authors:  E V Sugarbaker; C M McBride
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

10.  The treatment of state I melanoma of the extremities with regional hyperthermic isolation perfusion.

Authors:  K A Janoff; D Moseson; J Nohlgren; C Davenport; C Richards; W S Fletcher
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

View more
  3 in total

1.  Multidisciplinary Perioperative Management of Hyperthermic-Isolated Limb Perfusion for Malignant Melanoma: A Case Report.

Authors:  Raghav Gupta; Himanshu P Yadav; Nishkarsh Gupta; S V S Deo; Sushma Bhatnagar
Journal:  Indian J Surg Oncol       Date:  2021-08-03

2.  Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs.

Authors:  W C Barker; M P Andrich; H R Alexander; D L Fraker
Journal:  Eur J Nucl Med       Date:  1995-11

3.  Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases.

Authors:  Heiner Ruschulte; Serena Shi; William W Tseng; Kerstin Kolodzie; Philip C Crawford; Darren B Schneider; Mohammed Kashani-Sabet; David Minor; Christian Apfel; Stanley Pl Leong
Journal:  BMC Anesthesiol       Date:  2013-07-17       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.